|
Name |
Phomalone
|
| Molecular Formula | C13H18O5 | |
| IUPAC Name* |
1-[2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl]butan-1-one
|
|
| SMILES |
CCCC(=O)C1=C(C=C(C(=C1O)CCO)O)OC
|
|
| InChI |
InChI=1S/C13H18O5/c1-3-4-9(15)12-11(18-2)7-10(16)8(5-6-14)13(12)17/h7,14,16-17H,3-6H2,1-2H3
|
|
| InChIKey |
PTBQWWHUOMDVFS-UHFFFAOYSA-N
|
|
| Synonyms |
Phomalone; 159768-89-5; 1-[2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl]butan-1-one; 1-(2,4-Dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl)butan-1-one; DTXSID10166722; CHEBI:182590; ZINC5819671; Phomalone, >=95% (LC/MS-UV); 1-Butanone, 1-(2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl)-; NCGC00381307-01!1-[2,4-dihydroxy-3-(2-hydroxyethyl)-6-methoxyphenyl]butan-1-one
|
|
| CAS | 159768-89-5 | |
| PubChem CID | 178026 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 254.28 | ALogp: | 1.8 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 87.0 | Aromatic Rings: | 1 |
| Heavy Atoms: | 18 | QED Weighted: | 0.677 |
| Caco-2 Permeability: | -4.724 | MDCK Permeability: | 0.00001060 |
| Pgp-inhibitor: | 0.008 | Pgp-substrate: | 0.016 |
| Human Intestinal Absorption (HIA): | 0.274 | 20% Bioavailability (F20%): | 0.555 |
| 30% Bioavailability (F30%): | 0.658 |
| Blood-Brain-Barrier Penetration (BBB): | 0.183 | Plasma Protein Binding (PPB): | 64.66% |
| Volume Distribution (VD): | 1.065 | Fu: | 28.85% |
| CYP1A2-inhibitor: | 0.835 | CYP1A2-substrate: | 0.889 |
| CYP2C19-inhibitor: | 0.057 | CYP2C19-substrate: | 0.383 |
| CYP2C9-inhibitor: | 0.093 | CYP2C9-substrate: | 0.807 |
| CYP2D6-inhibitor: | 0.174 | CYP2D6-substrate: | 0.487 |
| CYP3A4-inhibitor: | 0.06 | CYP3A4-substrate: | 0.187 |
| Clearance (CL): | 13.073 | Half-life (T1/2): | 0.882 |
| hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.051 |
| Drug-inuced Liver Injury (DILI): | 0.659 | AMES Toxicity: | 0.309 |
| Rat Oral Acute Toxicity: | 0.092 | Maximum Recommended Daily Dose: | 0.017 |
| Skin Sensitization: | 0.738 | Carcinogencity: | 0.038 |
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.696 |
| Respiratory Toxicity: | 0.212 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002568 | ![]() |
0.755 | D0WY9N | ![]() |
0.320 | ||
| ENC002881 | ![]() |
0.450 | D03LGG | ![]() |
0.267 | ||
| ENC005954 | ![]() |
0.443 | D0U5CE | ![]() |
0.267 | ||
| ENC001513 | ![]() |
0.383 | D08VYV | ![]() |
0.259 | ||
| ENC004096 | ![]() |
0.379 | D07MEH | ![]() |
0.256 | ||
| ENC004983 | ![]() |
0.377 | D0Y6KO | ![]() |
0.253 | ||
| ENC002781 | ![]() |
0.375 | D0O1UZ | ![]() |
0.247 | ||
| ENC005636 | ![]() |
0.362 | D08EVN | ![]() |
0.244 | ||
| ENC004428 | ![]() |
0.356 | D0U0OT | ![]() |
0.239 | ||
| ENC000507 | ![]() |
0.350 | D0E9CD | ![]() |
0.238 | ||